Table 2 Correlation between clinicopathological factors and neuroendocrine differentiation
From: Is neuroendocrine differentiation a prognostic factor in poorly differentiated colorectal cancer?
Clinicopathological factors | Number(%) | NED | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|---|
+(SG1, SG2, SG3) | – | P value | OR | |||
Age | 0.955 | |||||
<65 years | 43(61.4%) | 22(15, 6, 1) | 21 | |||
≥65 years | 27(38.6%) | 14(7, 6, 1) | 13 | |||
Gender | 0.816 | |||||
Male | 36(51.4%) | 19(14, 4, 1) | 17 | |||
Female | 34(48.6%) | 17(8, 8, 1) | 17 | |||
Tumor location | 0.943 | |||||
Colon | 45(64.3%) | 23(13, 9, 1) | 22 | |||
Rectum | 25(35.7%) | 13(9, 3, 1) | 12 | |||
Lymph nodes retrieved | 0.492 | |||||
<12 | 18(25.7%) | 8(6, 1, 1) | 10 | |||
≥12 | 52(74.3%) | 28(16, 11, 1) | 24 | |||
T stage | 0.669a | |||||
T1 + T2 | 5(7.1%) | 2(2, 0, 0) | 3 | |||
T3 + T4 | 65(92.9%) | 34(20, 12, 2) | 31 | |||
N stage | 0.010* | 0.006* | 2.391 | |||
N0 | 19(27.1%) | 5(5, 0, 0) | 14 | |||
N1 + N2 | 51(72.9%) | 31(17, 12, 2) | 20 | |||
TNM stage | 0.018b,* | 0.755 | ||||
I | 2(2.9%) | 0(0, 0, 0) | 2 | |||
II | 17(24.3%) | 5(5, 0, 0) | 12 | |||
III | 51(72.8%) | 31(17, 12, 2) | 20 | |||